Correlation Between Ningbo MedicalSystem and China Publishing

Can any of the company-specific risk be diversified away by investing in both Ningbo MedicalSystem and China Publishing at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningbo MedicalSystem and China Publishing into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ningbo MedicalSystem Biotechnology and China Publishing Media, you can compare the effects of market volatilities on Ningbo MedicalSystem and China Publishing and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningbo MedicalSystem with a short position of China Publishing. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningbo MedicalSystem and China Publishing.

Diversification Opportunities for Ningbo MedicalSystem and China Publishing

0.61

Correlation Coefficient

Ningbo MedicalSystem  China Publishing

Poor diversification

The 3 months correlation between Ningbo and China is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Ningbo MedicalSystem Biotechno and China Publishing Media in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Publishing Media and Ningbo MedicalSystem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningbo MedicalSystem Biotechnology are associated (or correlated) with China Publishing. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Publishing Media has no effect on the direction of Ningbo MedicalSystem i.e., Ningbo MedicalSystem and China Publishing go up and down completely randomly.

Pair Corralation between Ningbo MedicalSystem and China Publishing

Assuming the 90 days trading horizon Ningbo MedicalSystem Biotechnology is expected to generate 0.72 times more return on investment than China Publishing. However, Ningbo MedicalSystem Biotechnology is 1.39 times less risky than China Publishing. It trades about -0.13 of its potential returns per unit of risk. China Publishing Media is currently generating about -0.16 per unit of risk. If you would invest  1,150  in Ningbo MedicalSystem Biotechnology on September 29, 2024 and sell it today you would lose (53.00) from holding Ningbo MedicalSystem Biotechnology or give up 4.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Ningbo MedicalSystem Biotechno  vs.  China Publishing Media

Ningbo MedicalSystem

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ningbo MedicalSystem Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ningbo MedicalSystem is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

China Publishing Media

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in China Publishing Media are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China Publishing may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Ningbo MedicalSystem and China Publishing

The main advantage of trading using opposite Ningbo MedicalSystem and China Publishing positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningbo MedicalSystem position performs unexpectedly, China Publishing can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Publishing will offset losses from the drop in China Publishing's long position.

The idea behind Ningbo MedicalSystem Biotechnology and China Publishing Media pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.